[Contribution to the use of a new anabolic steroid, Androstanazol, in the first and second stages of childhood].
D045930:Anabolic Agents / Q000627:therapeutic use*; D001798:Blood Proteins / Q000096:biosynthesis*; D001835:Body Weight / Q000187:drug effects*; D002675:Child, Preschool; D004798:Enzymes / Q000378:metabolism*; D001068:Feeding and Eating Disorders / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007223:Infant; D007228:Infant Nutrition Disorders / Q000150:complications*; D007231:Infant, Newborn; D008297:Male; D013197:Stanozolol / Q000627:therapeutic use*
D045930:Anabolic Agents; D001798:Blood Proteins; D004798:Enzymes; D013197:Stanozolol
Contributo all'impiego di un nuovo anabolizzante steroideo, l'Androstanazolo, nella 1a e 2a infanzia.